I look forward to the Immune remnant asset sale starting in November and then the biggest date March 2023 and the completion of the business combination. Let’s not forget the Final Decree that will follow soon after the remnant sale. Once that’s done, I can then get some shares of Cellectis. What a great company. Target shareholders / Longs have a good wait ahead people of Immune. Such is life. The in between news will be enjoyable. Be well. Penny.